Mary Srethapakdi

Title: Mary Srethapakdi: Innovator in Cancer Research

Introduction

Mary Srethapakdi is a prominent inventor based in Bangkok, Thailand. She has made significant contributions to the field of cancer research, particularly in the treatment of cell proliferative disorders and viral infections. Her innovative approaches have the potential to impact the lives of many patients suffering from these conditions.

Latest Patents

Mary Srethapakdi holds 1 patent for her invention titled "Methods for treating cell proliferative disorders and viral infections." This patent focuses on methods that utilize compounds to inhibit heat shock protein 90 proteins. The disclosed methods aim to block Rb negative or deficient cells in the G2/M phase of the cell cycle, leading to their rapid destruction. This innovative approach offers new hope for treating tumors associated with viral infections and certain viral infections themselves.

Career Highlights

Mary is affiliated with the Sloan-Kettering Institute for Cancer Research, where she conducts her research and develops her innovative methods. Her work is characterized by a commitment to advancing cancer treatment and improving patient outcomes.

Collaborations

One of her notable collaborators is Neal Rosen, with whom she has worked closely to further her research initiatives. Their partnership exemplifies the collaborative spirit that drives innovation in the scientific community.

Conclusion

Mary Srethapakdi's contributions to cancer research through her innovative patent demonstrate her dedication to improving treatment options for patients. Her work continues to inspire advancements in the field and holds promise for future breakthroughs.